These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 17010585)

  • 1. Novel vaccines and adjuvants for allergen-specific immunotherapy.
    Crameri R; Rhyner C
    Curr Opin Immunol; 2006 Dec; 18(6):761-8. PubMed ID: 17010585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotechnology-based allergy diagnosis and vaccination.
    Bhalla PL; Singh MB
    Trends Biotechnol; 2008 Mar; 26(3):153-61. PubMed ID: 18222557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic allergen modification in the development of novel approaches to specific immunotherapy.
    Mutschlechner S; Deifl S; Bohle B
    Clin Exp Allergy; 2009 Nov; 39(11):1635-42. PubMed ID: 19624521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-based vaccines for allergic disease.
    Spiegelberg HL; Takabayashi K; Beck L; Raz E
    Expert Rev Vaccines; 2002 Aug; 1(2):169-77. PubMed ID: 12901556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergen immunotherapy: novel approaches in the management of allergic diseases and asthma.
    Campbell D; DeKruyff RH; Umetsu DT
    Clin Immunol; 2000 Dec; 97(3):193-202. PubMed ID: 11112358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual immunotherapy: from biological extracts to recombinant allergens.
    Moingeon P
    Allergy; 2006; 61 Suppl 81():15-9. PubMed ID: 16792601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for converting allergens into hypoallergenic vaccine candidates.
    Vrtala S; Focke-Tejkl M; Swoboda I; Kraft D; Valenta R
    Methods; 2004 Mar; 32(3):313-20. PubMed ID: 14962766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in allergen immunotherapy.
    Nouri-Aria KT
    Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR9-based immunotherapy for allergic disease.
    Hayashi T; Raz E
    Am J Med; 2006 Oct; 119(10):897.e1-6. PubMed ID: 17000223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fighting food allergy: current approaches.
    Nieuwenhuizen NE; Lopata AL
    Ann N Y Acad Sci; 2005 Nov; 1056():30-45. PubMed ID: 16387675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines.
    Mascarell L; Van Overtvelt L; Moingeon P
    Immunol Allergy Clin North Am; 2006 May; 26(2):283-306, vii-viii. PubMed ID: 16701145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in the development of new methods of immunotherapy: potential application of immunostimulatory DNA-conjugated to allergens for treatment of allergic respiratory conditions.
    Creticos PS; Lichtenstein LM
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2003; (94):304-12; discussion 312-3. PubMed ID: 15119051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
    Crameri R
    Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingual vaccines based on wild-type recombinant allergens.
    Van Overtvelt L; Razafindratsita A; St-Lu N; Didierlaurent A; Batard T; Lombardi V; Martin E; Moingeon P
    Eur Ann Allergy Clin Immunol; 2006 Sep; 38(7):247-9. PubMed ID: 17124785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, engineering and in vitro evaluation of MHC class-II targeting allergy vaccines.
    Crameri R; Flückiger S; Daigle I; Kündig T; Rhyner C
    Allergy; 2007 Feb; 62(2):197-206. PubMed ID: 17298430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modular antigen-translocation as a novel vaccine strategy for allergen-specific immunotherapy.
    Crameri R; Kündig TM; Akdis CA
    Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):568-73. PubMed ID: 19680120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latex allergy: a model for therapy.
    Rolland JM; O'Hehir RE
    Clin Exp Allergy; 2008 Jun; 38(6):898-912. PubMed ID: 18498539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant allergens for immunotherapy.
    Valenta R; Niederberger V
    J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From allergen genes to new forms of allergy diagnosis and treatment.
    Vrtala S
    Allergy; 2008 Mar; 63(3):299-309. PubMed ID: 18269675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.